COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R) : MDxHealth réalise avec succès une augmentation de capital à hauteur de EUR 36 millions (USD 44 millions)(1)

22/03/2018 - 08:00

C ommuniqué de presse - Information règlementée - Information privilégiée - 22 mars 2018, 08h00 HEC I RVINE, CA, et HERSTAL (BELGIQUE) - le 22 mars 2018 - MDxHealth SA (Euronext Brussels: MDXH) un leader mondial dans [...]

Eckert & Ziegler BEBIG: Full-Year 2017 Results, return to profitability is been confirmed

22/03/2018 - 07:46

Press Release Regulated Information Seneffe - Belgium, March 22, 2018 - Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) announced today its consolidated results for the year ending [...]

Eckert & Ziegler BEBIG : Résultats 2017, retour à la rentabilité confirmé

22/03/2018 - 07:46

Informations réglementées Seneffe - Belgique, le 22 mars 2018 - Eckert & Ziegler BEBIG (Euronext : EZBG; Reuters : EZBG.BR; Bloomberg : EZBG:BB) vient d'annoncer aujourd'hui ses résultats consolidés pour l'exercice [...]

IBA SA : IBA Reports Full Year Results for 2017

22/03/2018 - 07:01

IBA Reports Full Year Results for 2017 Louvain-La-Neuve, Belgium, March 22, 2018 - IBA ( Ion Beam Applications SA , EURONEXT), the world's leading provider of proton therapy solutions for the treatment of cancer, today [...]

IBA SA : IBA annonce ses résultats annuels consolidés pour 2017

22/03/2018 - 07:01

IBA annonce ses résultats annuels consolidés pour 2017 Louvain-La-Neuve, Belgique, 22 mars, 2018 - IBA ( Ion Beam Applications SA , EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le [...]

VALNEVA Delivers Strong 2017 Financial Results and Advances Key R&D Programs

22/03/2018 - 07:01

Valneva Delivers Strong 2017 Financial Results and Advances Key R&D Programs The Company expects continued double digit product sales growth in 2018 and to invest further in R&D, notably the Lyme and Chikungunya [...]

VALNEVA publie de très bons résultats 2017 et avance sur ses programmes R&D clés

22/03/2018 - 07:01

Valneva publie de très bons résultats 2017 et avance sur ses programmes R&D clés Le Groupe prévoit de maintenir en 2018 une croissance à deux chiffres de ses ventes de produits et d'investir davantage en R&D, [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

22/03/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 22 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

VALNEVA annonce la publication de son Document de Référence

22/03/2018 - 07:01

Valneva annonce la publication de son Document de Référence Lyon (France), 22 mars 2018 - Valneva SE ("Valneva" ou "Le Groupe"), société de biotechnologie dédiée au développement, à la production et à la [...]

argenx announces expansion of its pipeline with addition of complement-targeted ARGX-117 for treatment of severe autoimmune diseases

22/03/2018 - 07:01

Potential for ARGX-117 to have synergistic effect with lead autoimmune compound ARGX-113 March 22, 2018 Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology [...]

Immutep Commences Patient Dosing in Additional TACTI-mel Cohort

21/03/2018 - 23:29

SYDNEY, Australia, March 21, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”) has announced the initiation of patient dosing in the new cohort of the TACTI-mel ( T wo ACT [...]

RavenQuest Begins Trading on Frankfurt Exchange Under Symbol “1IT”

21/03/2018 - 23:00

VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce that it has commenced trading on [...]

MDxHealth (R): MDxHealth Launches Capital Increase

21/03/2018 - 22:57

Press release - Regulated information - Inside information - 21 March 2018, 5:45 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM - 21 March 2018 - MDxHealth SA (Euronext Brussels: MDXH) a world leader in molecular diagnostics [...]

MDxHealth (R) : MDxHealth lance une Augmentation de Capital

21/03/2018 - 22:57

Communiqué de presse - Information réglementée - Information privilégiée - 21 mars 2018, 17h45 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 21 mars 2018 - MDxHealth SA (Euronext Brussels: MDXH) un leader mondial dans les [...]

Recording of the Fourth Quarter 2017 Investor Conference Webinar

21/03/2018 - 22:33

Olaine, 2018-03-21 22:33 CET (GLOBE NEWSWIRE) -- The recorded AS “Olainfarm” webinar is available online: http://ej.uz/OLF_Q4_2017 , and the presentation, demonstrated during the webinar, is available in the attachment [...]

Sienna Biopharmaceuticals Appoints John W. Smither as Chief Financial Officer

21/03/2018 - 22:30

WESTLAKE VILLAGE, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced the appointment of John W. Smither as the Company’s Chief Financial Officer. Mr. Smither will [...]

Kane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business Update

21/03/2018 - 21:30

WINNIPEG, Manitoba, March 21, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) is pleased to announce its 2017 Year End and Fourth Quarter Financial Results. [...]

Assure Holdings Corp. Announces Update

21/03/2018 - 21:25

PARKER, Colo., March 21, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services is providing the following update [...]

Cellectar Reports 2017 Financial Results and Provides a Corporate Update

21/03/2018 - 21:10

MADISON, Wis., March 21, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]